Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan

Health Policy and Planning

Volumn 17, Issue 2, 2002, Pages 178-186

  Khan, M A ^a   Walley, J D ^b   Witter, S N ^c   Imran, A ^d   Safdar, N ^a  

^a Association for Social Development   (Pakistan)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d USAID Office   (Pakistan)

Author keywords

Cost effectiveness analysis; Costing study; Direct observation; DOT; Pakistan; Patient compliance; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAKISTAN; PATIENT COMPLIANCE; TUBERCULOSIS;

EID: 0036263417     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/17.2.178     Document Type: Article

References (7)

1. Comparison of cost-effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: Experience from rural South Africa
2. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand
3. Tuberculosis in Pakistan: Socio-cultural constraints and opportunities in treatment
4. Directly observed therapy and treatment adherence
5. Effectiveness of the direct observation component of DOTS for tuberculosis: A randomised controlled trial in Pakistan
6. Coping with Africa′s increasing tuberculosis burden: Are community supervisors an essential component of the DOT strategy?
7. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis